Chemical firms' endocrine testing "irrelevant"

Top EU scientist says Cefic research initiative needs to pay more attention to real-world effects

A chemical industry programme of testing for environmental and human health impacts of potential endocrine-disrupting chemicals (EDCs) lacks relevance to the real-life effects of the substances, according to a member of the EU's chief toxicology committee.

Professor Peter Calow of Sheffield university in the UK was addressing the fourth annual conference of industry association Cefic's long-range research initiative (LRI), a voluntary programme launched in 1999 and building on existing research funding (EED 16/06/99). The LRI will fund €23m worth of projects from 2002 until 2005, down from €23.8m annually at the start of the programme.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.